<DOC>
	<DOC>NCT02587247</DOC>
	<brief_summary>Evaluation of the sensitivity of the immuno-PET PET / CT pretargeted with the bispecific anti-CEA x anti-HSG TF2 antibody and IMP-288 peptide labeled with Gallium-68 for imaging potential candidate patients for surgery of local resection of one or more metastases at diagnosis or during relapse CCR expressing CEA.</brief_summary>
	<brief_title>ImmunoTEP With 68-Ga in Metastatic Colo Rectal Cancer</brief_title>
	<detailed_description>Injection of a bispecific anti-CEA x anti-HSG antibody TF2 (120 nmoles) and 30 hours later IMP-288 peptide labeled with gallium-68 (3 to 6 nmoles/150 MBq). A TEP imaging acquisition is plannified 60 min after the 68-Ga injection.</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Existence of one or more metastases of of colorectal cancer (CRC) expressing the CEA , potentially accessible by surgical or thermo resection at the moment of the diagnosis or at relapse. OR Isolated and progressive elevation of plasma CEA during the monitoring of CRC with high metastatic risk More than 18 years Negative pregnancy test for women of childbearing age. Women of childbearing age should take effective continuous contraception for 3 months. At least 4 weeks after the last treatment and after recovery of potential toxicity Karnofsky more than 70 or ECOG 01 Life expectancy of at least 6 months CEA positive immunohistochemistry or plasma CEA supperior or equal to the normal level Creatinin less or equal 200 micromol/L Signed informed consent geographical proximity Pregnancy or breastfeeding Serious illness or comorbidity assessed risk History of other cancer within 5 years, with the exception of skin carcinomas other than melanomas or insitu carcinoma of the cervix Antiantibody presence in patients who have already received antibody Hypersensitivity to antibodies or proteins Intellectual inability to sign the informed consent Insulindependent diabetic patient or noninsulin dependent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>